CRO Quintiles has been recognized for its pioneering work creating big data solutions that help pharmaceutical organizations improve their probability of success throughout the drug development process, with a Computerworld Data+ Editor's Choice Award for its Quintiles Infosario platform.
"The drug development process is predicated upon the availability of high-quality data with which to collaborate and make informed decisions at every step of the way during the evolution of a product or treatment," said Richard Thomas, Quintiles chief information officer.
Quintiles Infosario is an end-to-end suite of technologies that power the pharmaceutical product development process. Infosario is able to break down silos combining massive quantities of scientific and operational data collected during clinical development with tens of millions of real-world patient medical records and population data. Providing researchers and drug developers with the knowledge in this data improves decision making and, ultimately, increases the probability of success of a product's lifecycle.
Computerworld's Data+ awards recognize projects that illustrate how big data can be mined and analyzed to predict trends and improve the probability of success.